Positive Expiratory Pressure Devices Market
Number of pages: 100 | Report Format: PDF | Published date: April 18, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 993.12 million |
|
Market Size Value in 2031 |
US$ 2,139.2 million |
|
CAGR |
8.9% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global positive expiratory pressure devices market was valued at US$ 993.12 million in 2022 and is expected to register a revenue CAGR of 8.9% to reach US$ 2,139.2 million by 2031.
Positive Expiratory Pressure Devices Market Fundamentals
Positive expiratory pressure (PEP) devices are medical devices that help improve lung function and clear mucus from the airways. These devices treat respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). PEP devices resist exhalation, creating a back pressure that helps keep the airways open and increase the exhaled air volume. This increased pressure also helps to loosen and mobilize mucus, making it clear from the airways easier.
PEP devices come in various types, including handheld devices, mouthpieces, and facial masks. Handheld devices typically consist of a mouthpiece attached to a resistance valve, which can be adjusted to provide different pressure levels. Mouthpieces are like handheld devices but are designed to be used without a resistance valve. Facial masks deliver PEP therapy to patients who cannot use a mouthpiece or handheld device.
[65445]
Positive Expiratory Pressure Devices Market Dynamics
The rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is a primary driver for the global positive expiratory pressure devices market. These devices help clear mucus and improve lung function, which is important for managing these conditions. The development of more advanced and user-friendly positive expiratory pressure devices has increased their adoption among patients and helped boost the global positive expiratory pressure devices market. Furthermore, the growing awareness about the importance of maintaining good respiratory health has increased the use of positive expiratory pressure devices. Patients are becoming more proactive in managing their respiratory conditions, and healthcare providers are recommending PEP devices as a part of their treatment plans.
However, some positive expiratory pressure devices can be expensive, which could limit their affordability for some patients. This could also limit the market revenue growth, particularly in regions with lower healthcare spending. Similarly, several alternative treatments, such as bronchodilators and nebulizers, are available for respiratory diseases. Some patients may prefer these treatments over PEP devices, which could limit the demand for PEP devices. Moreover, despite the growing awareness about respiratory health, many patients and healthcare providers may not know about PEP devices and their benefits. This could limit the adoption of PEP devices, particularly in regions with low awareness levels. Additionally, lack of standardization and challenges in manufacturing and distribution in developing nations are some restraints impeding the overall positive expiratory pressure devices market revenue growth.
Positive Expiratory Pressure Devices Market Ecosystem
The global positive expiratory pressure devices market is analyzed from four perspectives: product type, application, end-user, and region.
Positive Expiratory Pressure Devices Market by Product Type
[546454]
Based on the product type, the global positive expiratory pressure devices market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices.
The mouthpiece PEP device segment dominated the market with the principal revenue share in 2022, attributed to its widespread usability. Mouthpiece PEP devices typically consist of a mouthpiece attached to a resistance valve, which can be adjusted to provide different pressure levels. The patient inhales through the device, which creates a resistance to inhalation and exhales forcefully against the resistance valve, creating positive pressure in the airways. This increased pressure helps to keep the airways open and improve lung function while also loosening and mobilizing mucus, making it easier to clear from the airways. Healthcare providers often recommend Mouthpiece PEP devices as part of a patient’s respiratory therapy regimen. They are typically used multiple times a day for several minutes and can be used in various settings, including hospitals, clinics, and at home. These factors contribute to the revenue growth of the mouthpiece PEP devices segment.
The bottle PEP devices segment accounts for a prominent revenue share. Bottle PEP devices consist of a clear plastic bottle with a mouthpiece and a one-way valve. The patient exhales into the mouthpiece, creating positive pressure in the airways. The air then flows through the one-way valve into the bottle, creating resistance to exhalation. This increased pressure helps to keep the airways open and improve lung function while also loosening and mobilizing mucus, making it easier to clear from the airways. The advantages of bottle PEP devices include their ease of use and ability to provide a consistent pressure level. They also do not require the patient to have sufficient respiratory muscle strength to generate the necessary expiratory pressure. These advantages promote the revenue growth of the bottle PEP devices segment.
Positive Expiratory Pressure Devices Market by Application
Based on the application, the global positive expiratory pressure devices market is segmented into atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD.
Due to its rising prevalence, the COPD (chronic obstructive pulmonary disease) segment dominated the market with the largest revenue share in 2022. According to WHO’s March 2023 factsheet, COPD is the third leading cause of death globally, which caused around 3.23 million deaths in 2019. COPD is a progressive respiratory disease characterized by airflow obstruction, inflammation, and lung damage. The primary symptoms of COPD include cough, sputum production, and shortness of breath, which can worsen over time. Genetic, environmental, and lifestyle factors, including smoking, air pollution, and exposure to occupational dust and chemicals, cause the disease. PEP Devices are often used as a part of respiratory therapy in patients with COPD. PEP therapy can help to improve lung function, increase exercise tolerance, and reduce symptoms such as shortness of breath and cough. PEP devices resist exhalation, creating a back pressure that helps keep the airways open and increase the exhaled air volume. This increased pressure also helps to loosen and mobilize mucus, making it clear from the airways easier. These overall factors contribute to the revenue growth of the COPD segment.
Similarly, the asthma segment also accounts for a prominent revenue share in the market. Asthma is a chronic respiratory disease that affects millions of people worldwide. It is characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, and shortness of breath. Various factors can trigger asthma, including allergens, air pollution, exercise, and stress. In patients with asthma, PEP devices are frequently utilized as a component of respiratory therapy. PEP therapy can help to improve lung function, increase exercise tolerance, and reduce symptoms such as wheezing and shortness of breath.
Positive Expiratory Pressure Devices Market by End User
Based on the end user, the global positive expiratory pressure devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others.
The hospitals & clinics segment is a key player in the positive expiratory pressure devices market with the largest revenue share in 2022, owing to the large footfall. The hospitals & clinics are important for diagnosing and treating respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, for which PEP therapy may be used. Hospitals and clinics typically have specialized respiratory therapy departments equipped with various types of PEP devices, including mouthpieces, bottle PEP devices, and others. These devices are part of a patient’s respiratory therapy regimen and may be recommended by healthcare providers to help manage respiratory disease symptoms. Hospitals and clinics are also important for diagnosing and monitoring respiratory diseases. They may perform tests such as spirometry, which measures lung function, and bronchoscopy, which allows doctors to visualize the airways and collect samples for analysis. These overall factors contribute to the revenue growth of the hospitals & clinics segment.
The ambulatory surgical center’s segment had the second-largest revenue share in 2022. Ambulatory surgical centers (ASCs) are healthcare facilities that specialize in providing same-day surgical care to patients. These centers play a role in the PEP devices market by providing outpatient respiratory therapy services. ASCs may have respiratory therapy departments equipped with PEP devices, including mouthpieces and bottle PEP devices. These devices help manage respiratory disease symptoms and improve lung function in patients with asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. PEP devices may be used with other treatments, such as bronchodilator medications or corticosteroids, to provide a comprehensive respiratory therapy regimen. ASCs may also provide education and training to patients on how to use PEP devices effectively and monitor their respiratory health. These overall factors contribute to the revenue growth of the ambulatory surgical centers segment.
Positive Expiratory Pressure Devices Market by Region
Based on region, the global positive expiratory pressure devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global positive expiratory pressure devices market with the largest revenue share in 2022, attributed to the presence of key market players and an increase in occurrences of respiratory disorders. Additionally, companies across the region are continuously improving and launching new PEP devices. They are involved in partnerships, mergers, and acquisitions, which are also expected to strengthen the positive expiratory pressure devices market outlook.
Positive Expiratory Pressure Devices Market Competitive Landscape
The prominent players operating in the global positive expiratory pressure devices market are:
Positive Expiratory Pressure Devices Market Strategic Developments
Positive expiratory pressure (PEP) devices are medical devices that help improve lung function and clear mucus from the airways.
The expected size of the global positive expiratory pressure devices market in 2031 is US$ 2.13 billion.
The revenue CAGR of the global positive expiratory pressure devices market during the forecast period is expected to be 8.9% from 2023 to 2031.
The lack of standardization and challenges in manufacturing and distribution in developing nations are factors restricting global positive expiratory pressure devices market revenue growth to its full potential.
Some prominent players operating in the global positive expiratory pressure devices market are Smiths Medical (ICU Medical, Inc.), Koninklijke Philips N.V., AirPhysio, PARI GmbH, and Monaghan Medical Corporation.
*Insights on financial performance are subject to the availability of information in the public domain